Osteoporosis treatment with risedronate: a population pharmacokinetic model for the description of its absorption and low plasma levels
Crossref DOI link: https://doi.org/10.1007/s00198-021-05944-0
Published Online: 2021-05-17
Published Print: 2021-11
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Cardozo, B.
Karatza, E.
Karalis, V. http://orcid.org/0000-0003-0492-0712
Text and Data Mining valid from 2021-05-17
Version of Record valid from 2021-05-17
Article History
Received: 4 January 2021
Accepted: 31 March 2021
First Online: 17 May 2021
Declarations
:
: Not applicable.
: None.